Advocacy intelligence hub — real-time data for patient organizations
VA Office of Research and Development — PHASE1
Jennifer Leddon — PHASE1
Catalina Lee Chang — PHASE1
National Institute of Neurological Disorders and Stroke (NINDS) — PHASE1, PHASE2
Jecho Biopharmaceuticals Co., Ltd. — PHASE1, PHASE2
Black Diamond Therapeutics, Inc. — PHASE2
Sabine Mueller, MD, PhD — PHASE1, PHASE2
Trogenix ltd — PHASE1, PHASE2
Tetragon Biosciences Ltd — PHASE1
University of Zurich — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Wenbin Li
Beijing Tiantan Hospital
Patrick Roth, MD
University of Zurich
Xiaoguang Qiu
Beijing Tiantan Hospital
Wolfgang Wick, MD
Neurology Clinic and National Center for Tumor Diseases
Elizabeth R Gerstner, MD, MD
Massachusetts General Hospital
📍 LIBERTY, MO
Ashley Ghiaseddin, MD, M.D
University of Florida
📍 GAINESVILLE, FL